In Pursuit of Better Outcomes for All
Only a fraction of the patients who could benefit from precision diagnostics and targeted therapeutics have access to them.
We founded Aventus Health to change that.
Driven by a vision for transforming the delivery of healthcare services, the three co-founders of Aventus Health established the company in 2015 as they opened its first compounding pharmacy. We have since rapidly expanded to include multiple pharmacies, a community hospital, multiple genetic, toxicology and clinical laboratories, novel hospital outreach programs and advanced medical billing and data analytics services. We are additionally developing MEDCI Oviedo—a state-of-the-art medical campus scheduled to open in 2020.
With our novel approach and straightforward best practices, Aventus Health today is ensuring more healthcare providers get the data, services and resources they need to profitably deliver superior precision medicine. Even more, we are purposefully creating an ideal platform for delivering predictive and prescriptive analytics with the insights of diverse laboratory testing (blood, toxicology, genetic and molecular) to create an ecosystem for discovery analytics and new medical paradigms tomorrow.
Chief Executive Officer
Mr. Oliver Dawoud co-founded Aventus Health in 2015 and has been its Chief Executive Officer since. Mr. Dawoud is responsible for setting the overall direction and strategy of Aventus health and oversees the development and expansion of Aventus Health branded and affiliated companies to include multiple genetics and diagnostic labs, hospital outreach programs, data analytics and billing services. Mr. Dawoud also co-founded Precision Pharmacy in 2012 and remains a co-owner and adviser for this Tampa-based sterile compounding pharmacy. Mr. Dawoud is currently focused on directing the management of Aventus Health’s existing portfolio and evaluating new development and investment opportunities with the executive leadership team. He attended Boston University where he received his B.S in Biology in 2012.
Nagi Youssef, MD
Dr. Nagi Youssef co-founded Aventus Health and currently serves as the company’s chairman. With degrees in medicine and surgery, Dr. Youssef practiced internal medicine for 25 years before moving his family to the U.S. in 1993. In 2005, he left his medical practice to teach, ultimately leading the development of a new curriculum for the Pharmacy Technicians Associates Program Seminole College. He also co-founded Precision Pharmacy with his son Oliver Dawoud, and his recent focus has been overseeing the development of MEDCI, a state-of-the-art medical facility in Oviedo, Florida scheduled to open in 2020 and featuring an urgent care center, outpatient surgery, on-site pharmacy, research labs, sixty physician specialties and a conference center. Dr. Youssef is a member of the Winter Springs/Oviedo Chamber of Commerce and the exclusive sponsor of the ABA’s Orlando Waves Basketball team.
Chief Business Development Officer
Mr. Tamer Girgis is the third co-founder of Aventus Health. In his role as President, Mr. Girgis spearheads operations and product development across the Aventus Health portfolio and takes a leading role in overall business development. He also served as interim CEO of North Oak Regional Medical Center through first quarter of 2018 following Aventus Health’s acquisition of the hospital in 2017. A year before co-founding Aventus Health, Mr. Girgis and a business partner acquired a failing pharmacy in Chantilly, VA that serves the DC metro area. Today Akina Pharmacy is a profitable sterile compounding pharmacy and one of the local area’s largest employers. Mr. Girgis remains an owner and plays an advisory role in the pharmacy’s business development, as he does with two pharmacies in New Jersey which he co-founded in 2007 -2008. Mr. Girgis received his Doctorate Degree in Pharmacy from Rutgers College in 2006.
Chief Operating Officer
Mr. Nick Savas joined Aventus Health in 2016 to oversee the operational development and management of Aventus Biolabs, including all staffing and instrumentation. Prior to joining Aventus, he was a technical consultant with Medical Source Team, Inc., where he specialized in diagnostic laboratory compliance and licensure. Mr. Savas began his laboratory career at Castle Medical, at the time ranked fourth on INC 500’s list of fastest growing companies and first in the healthcare category. While there, he worked as an instrumentation specialist in the chemistry analyzer department to help physician offices obtain the appropriate licensure, equipment, personnel, and compliance documentation required for setting up an in-house laboratory. At Aventus Health, Mr. Savas additionally oversees the Aventus Biolabs 1099 sample distribution network, consults on Aventus Health hospital acquisitions and is working with external partners to develop a compliant and long lasting HOPD model for diagnostic laboratories.
Michelle Taylor, MD
Dr. Michelle Taylor obtained her medical degree at Des Moines University – College of Osteopathic Medicine, one of the oldest and highest ranked Osteopathic programs in the country. She completed her residency in Anatomic and Clinical Pathology from MetroHealth Medical Center, Cleveland, OH and a fellowship in Transfusion Medicine at Mayo Clinic, in Rochester, Minnesota. Dr. Taylor previously served as the Senior Vice President of Clinical Laboratories at ApriHealth (formerly Transfuse Solutions) and acted as the Assistant Medical Director and Medical Director for other laboratories. As Medical Director at Aventus Biolabs, Dr. Taylor is able to apply her diverse background and experience in both entrepreneurial and corporate lab environments. She also continues to work with clinicians and data scientists at ApriHealth to derive hyper-personalized algorithms for patient blood management and laboratory test utilization.